408 related articles for article (PubMed ID: 32414632)
1. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
2. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
Chandrakumar A; Zohni H; El-Matary W
Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
[TBL] [Abstract][Full Text] [Related]
4. Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
Colman RJ; Rubin DT
J Crohns Colitis; 2015 Apr; 9(4):312-7. PubMed ID: 25616487
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease.
Azimirad M; Krutova M; Balaii H; Kodori M; Shahrokh S; Azizi O; Yadegar A; Aghdaei HA; Zali MR
Anaerobe; 2020 Feb; 61():102113. PubMed ID: 31698044
[TBL] [Abstract][Full Text] [Related]
7. [Infection rate and clinical characteristics of toxigenic
Li D; Guo S; Guan DX; Zhao CN; Xu XW
Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):564-569. PubMed ID: 32605340
[No Abstract] [Full Text] [Related]
8. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
[TBL] [Abstract][Full Text] [Related]
9. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and antibiotic resistance of Clostridioides difficile in patients with inflammatory bowel disease from two hospitals in China.
Lv T; Zheng L; Wu T; Shen P; Chen Y
J Glob Antimicrob Resist; 2022 Sep; 30():252-258. PubMed ID: 35764214
[TBL] [Abstract][Full Text] [Related]
14. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
[TBL] [Abstract][Full Text] [Related]
15. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
[TBL] [Abstract][Full Text] [Related]
16. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
Albarrak AA; Romana BS; Uraz S; Yousef MH; Juboori AA; Tahan V
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):929-935. PubMed ID: 30827274
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.
Fang SB; Song YQ; Zhang CY; Wang LB
World J Pediatr; 2022 Jan; 18(1):27-36. PubMed ID: 34800281
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic synergism of
Bassotti G; Fruganti A; Stracci F; Marconi P; Fettucciari K
World J Gastroenterol; 2023 Jan; 29(4):582-596. PubMed ID: 36742168
[No Abstract] [Full Text] [Related]
19. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]